Di Giambenedetto S - Search Results

1

Long-term data on the efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multi-centre cohort of HIV-1-infected, virologically suppressed patients.

Baldin G, Ciccullo A, Rusconi S, Capetti A, Sterrantino G, Colafigli M, d'Ettorre G, Giacometti A, Cossu MV, Borghetti A, Gennari W, Mussini C, Borghi V, Di Giambenedetto S. Baldin G, et al. Among authors: di giambenedetto s. Int J Antimicrob Agents. 2019 Dec;54(6):728-734. doi: 10.1016/j.ijantimicag.2019.09.002. Epub 2019 Sep 12. Int J Antimicrob Agents. 2019. PMID: 31521809 Free article.

2

Interpretation systems for genotypic drug resistance of HIV-1.

De Luca A, Antinori A, Di Giambenedetto S, Cingolani A, Colafigli M, Perno CF, Cauda R. De Luca A, et al. Among authors: di giambenedetto s. Scand J Infect Dis Suppl. 2003;106:29-34. doi: 10.1080/03008870310009623. Scand J Infect Dis Suppl. 2003. PMID: 15000579 Review.

3

Liver fibrosis stage predicts early treatment outcomes with peginterferon plus ribavirin in HIV/hepatitis C virus co-infected patients.

De Luca A, Di Giambenedetto S, Cingolani A, Ammassari A, Marasca G, Tumbarello M, Fantoni M, Tamburrini E, Cauda R. De Luca A, et al. Among authors: di giambenedetto s. AIDS. 2004 Jul 23;18(11):1602-4. doi: 10.1097/01.aids.0000131365.67704.a4. AIDS. 2004. PMID: 15238782

4

CD4 cell-monitored treatment interruption in patients with a CD4 cell count > 500 x 106 cells/l.

Mussini C, Bedini A, Borghi V, Guaraldi G, Esposito R, Barchi E, Enilia R, Cozzi-Lepri A, Philips AN, Ortolani P, Bratt G, Eriksson LE, Sighinolfi L, Cossarizza A, d'Arminio Monforte A, De Luca A, Di Giambenedetto S, Antinori A; International Study Group on CD4-monitored Treatment Interruptions. Mussini C, et al. Among authors: di giambenedetto s. AIDS. 2005 Feb 18;19(3):287-94. AIDS. 2005. PMID: 15718839

5

Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients.

Torti C, Lapadula G, Uccelli MC, Quiros-Roldan E, Regazzi M, Ladisa N, Micheli V, Orani A, Patroni A, Caputo SL, Tirelli V, Di Giambenedetto S, Cologni G, Costarelli S, Gargiulo F, Manca N, Carosi G; RADAR Study Group of MASTER Cohort. Torti C, et al. Among authors: di giambenedetto s. Int J Antimicrob Agents. 2007 Feb;29(2):185-90. doi: 10.1016/j.ijantimicag.2006.08.015. Epub 2006 Oct 2. Int J Antimicrob Agents. 2007. PMID: 17011754

6

Genotypic resistance to lopinavir and fosamprenavir with or without ritonavir of clinical isolates from patients failing protease inhibitors-containing HAART regimens: prevalence and predictors.

Di Giambenedetto S, Bacarelli A, Pinnetti C, Colafigli M, Prosperi M, Gatti G, Cauda R, De Luca A. Di Giambenedetto S, et al. Scand J Infect Dis. 2007;39(9):813-8. doi: 10.1080/00365540701367728. Scand J Infect Dis. 2007. PMID: 17701721

7

Declining prevalence of HIV-1 drug resistance in treatment-failing patients: a clinical cohort study.

Di Giambenedetto S, Bracciale L, Colafigli M, Cattani P, Pinnetti C, Bacarelli A, Prosperi M, Fadda G, Cauda R, De Luca A. Di Giambenedetto S, et al. Antivir Ther. 2007;12(5):835-9. Antivir Ther. 2007. PMID: 17713168

8

Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen.

Colafigli M, Di Giambenedetto S, Bracciale L, Tamburrini E, Cauda R, De Luca A. Colafigli M, et al. Among authors: di giambenedetto s. HIV Med. 2008 Mar;9(3):172-9. doi: 10.1111/j.1468-1293.2007.00541.x. Epub 2008 Jan 21. HIV Med. 2008. PMID: 18217998 Free article.

9

Genotypic resistance profile and clinical progression of treatment-experienced HIV type 1-infected patients with virological failure.

Di Giambenedetto S, Colafigli M, Pinnetti C, Bacarelli A, Cingolani A, Tamburrini E, Cauda R, de Luca A. Di Giambenedetto S, et al. AIDS Res Hum Retroviruses. 2008 Feb;24(2):149-54. doi: 10.1089/aid.2007.0070. AIDS Res Hum Retroviruses. 2008. PMID: 18240962

10

Virological suppression reduces clinical progression in patients with multiclass-resistant HIV type 1.

Bracciale L, Di Giambenedetto S, Colafigli M, La Torre G, Prosperi M, Santangelo R, Marchetti S, Cauda R, Fadda G, De Luca A. Bracciale L, et al. Among authors: di giambenedetto s. AIDS Res Hum Retroviruses. 2009 Mar;25(3):261-7. doi: 10.1089/aid.2008.0136. AIDS Res Hum Retroviruses. 2009. PMID: 19292594

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

292 results

Search Page